Dublin, May 17, 2024 (GLOBE NEWSWIRE) -- The "Non Hodgkin Lymphoma (NHL) Global Market Report 2024" report has…
Fake studies have flooded publishers of top scientific journals,. leading to thousands of retractions and millions of dollars in lost…
AbbVie (ABBV) inks an option-to-license and collaboration deal with Gilgamesh to develop next-generation therapies for psychiatric disorders.…
Eli Lilly (LLY), Novo Nordisk (NVO), Pfizer (PFE) and AbbVie (ABBV) announce their first-quarter results.…
AbbVie has two successors that could offset the losses from its blockbuster drug Humira. Meanwhile, UnitedHealth Groups CEO will testify…
AbbVie Deutschland GmbH & Co. KG: Ludwigshafen (ots) - - Modernste Rahmenbedingungen für Forscher*innen im Kampf gegen u.a. Alzheimer und…
Wien (www.aktiencheck.de) - AbbVie-Aktienanalyse von der Raiffeisen Bank International AG:
Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), nimmt die…
ABBV earnings call for the period ending March 31, 2024.…
…
Jim Cramer offers his take on companies outside the CNBC Investing Club’s portfolio.…
Skyrizi brought in $2.01 billion in sales, just barely trailing the $2.27 billion generated by the struggling Humira.…
…
AbbVie raises annual profit forecast on strong Skyrizi sales…
AbbVie hikes 2024 earnings guidance as Q1 beat estimates, shares up…
AbbVie earnings beat by $0.04, revenue topped estimates…
…
Dublin, April 24, 2024 (GLOBE NEWSWIRE) -- The "Weight Loss Drugs Global Market Report 2024" report has been…
Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk…
Investor focus is likely to be on the sales of AbbVies (ABBV) blockbuster immunology drugs Rinvoq and Skyrizi when it…
…
…
…
Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABBVIE INC US00287Y1091 1,55 USD 1,4449 EUR AMERICAN EQUITY INVESTMENT LIFE HOLDING ... US0256762065…
AbbVie, Salesforce, General Electric, The TJX Companies and UBS Group are part of the Zacks top Analyst Blog.…
Todays Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), Salesforce, Inc. (CRM) and General…
…
Kulmbach (www.aktiencheck.de) - Pfizer-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Pfizer Inc. (ISIN: US7170811035,…
…
Landos Biopharma stock downgraded at H.C. Wainwright amid AbbVie acquisition…
While AbbVie (ABBV) is set to buy Landos Biopharma, Novo Nordisk (NVO) is set to acquire Cardior Pharmaceuticals. FDA approves…
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…
AbbVie Inc (NYSE:ABBV)s approximately $137.5 million acquisition of Landos Biopharma is a strategic move by the pharmaceutical research and development...…
Wenig Kursbewegung gegenwärtig bei der Aktie von AbbVie . Der jüngste Kurs betrug 179,17 US-Dollar. Kaum auffällig ist aktuell an…
AbbVie (ABBV) offers to buy Landos Biopharma (LABP) to boost its portfolio in inflammatory and autoimmune disease drugs.…
…
AbbVie to buy Landos to expand pipeline of immunity-related illnesses…
- Landos’ lead asset, NX-13, is a first-in-class, oral NLRX1 agonist in Phase 2 for the treatment of ulcerative colitis…
…
AbbVie executive sells over $3.7 million in company stock…
Am 15. September 2023 erschien der Alzheimer-Aktien-Report von André Fischer, der Biotech-Firmen behandelte, die sich auf die Bereiche Demenz, Parkinson…
Mastercard, AbbVie, Salesforce, Thermo Fisher Scientific and Mondelez are included in this Analyst Blog.…
…
Todays Research Daily features new research reports on 16 major stocks, including Mastercard Incorporated (MA), AbbVie Inc. (ABBV) and Salesforce,…
Am US-amerikanischen Aktienmarkt liegt das Wertpapier von AbbVie aktuell im Minus. Die Aktie kostete zuletzt 179,37 US-Dollar. Heute hat sich…
…
Der Markt für Antikörper-Wirkstoff-Konjugate, den sogenannten ADCs, bleibt siedend heiß. In den USA gab es in den vergangenen Quartalen in…
Der Markt für Antikörper-Wirkstoff-Konjugate, den sogenannten ADCs, bleibt siedend heiß. In den USA gab es in den vergangenen Quartalen in…
Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Global Anxiety Disorders And Depression Treatment Market Analysis & Forecast…
For Medical and Trade media.
· Foslevodopa-foscarbidopa will soon be available for eligible patients with advanced levodopa-responsive Parkinson’s disease…
…